Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research

Boston, MA – September 19, 2012 – marcus evans, a world leading provider of strategic conferences is pleased to introduce the Life Cycle of Orphan Drug Development & Commercialization Conference, January 16-18, 2013 in Boston, Mass.